Estimated impact on disability-adjusted life years (DALYs) of GLP1-RA or SGLT2-i treatment among people with diabetes taking insulin across treatment scenarios, showing overall among all countries regardless of sample size, and the subset of countries with <i>N</i> > 100 people with diabetes reporting insulin use.
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Estimated impact on disability-adjusted life years (DALYs) of GLP1-RA or SGLT2-i treatment among people with diabetes taking insulin across treatment scenarios, showing overall among all countries regardless of sample size, and the subset of countries with N > 100 people with diabetes reporting insulin use.
创建时间：
2025-04-17
